← All indications
Ventricular Fibrillation
A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.
Drugs by status
Approved for this indication (2)
Phase 4 trials (2)
Phase 3 trials (9)
Phase 2 trials (3)
Other trials (1)
Organizations
Organization Involved with Phase 4 Indications (5)
Organization Involved with Phase 3 Indications (42)
- National Heart, Lung, and Blood Institute (NHLBI)
- United States Army
- American Heart Association
- Atlantic Health System
- Baylor University
- Boston University
- Dartmouth University
- Emory University
- Geisinger Clinic
- University of Washington
- Henry Ford Health System
- Johns Hopkins University
- Maimonides Medical Center
- Northwell Health
- Northwestern University
- Rhode Island Hospital
- Rutgers University
- University of Nebraska
- University of Rochester
- University of South Carolina
- University of Southern California
- State University of New York
- University of California, Berkeley
- University of California, Davis
- University of Utah
- Icahn School of Medicine at Mount Sinai
- University of Minnesota
- Rush University
- University of Montreal
- University of Sao Paulo
- +12 more
Organization Involved with Phase 2 Indications (3)
Organization Involved with Other Experimental Indications (1)